skip to main content

Insulin name confusion — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardDispensing and SupplyInsulin name confusionGPhC CRA

A prescription requests insulin aspart but the patient usually receives insulin glargine and is unsure why it changed. What is the legal classification/requirement?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Clarify with the prescriber before supply because rapid-acting and basal insulins are not interchangeable

Insulin product confusion can cause severe hypo- or hyperglycaemia. In this scenario, the pharmacist should prioritise safe supply, appropriate counselling and timely referral or clarification where needed. This is the single best answer because the other options would either delay assessment, ignore a clinically significant risk, or create an unsafe legal or professional outcome.

Reference: BNF; MEP